Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Solid second cancers following Hodgkin's disease

M A Tucker1

  • 1Genetic Epidemiology Branch, National Cancer Institute, Bethesda, Maryland.

Hematology/Oncology Clinics of North America
|April 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia.

Genetics in medicine : official journal of the American College of Medical Genetics·2021
Same author

TET2 binds the androgen receptor and loss is associated with prostate cancer.

Oncogene·2016
Same author

A 20 Year Clinical and Laboratory Study of Familial B-Chronic Lymphocytic Leukemia in a Single Kindred.

Leukemia & lymphoma·2016
Same author

Revisiting the cost of carnivory in mammals.

Journal of evolutionary biology·2016
Same author

Reliability of 24-h void frequency as an index of hydration status when euhydrated and hypohydrated.

European journal of clinical nutrition·2016
Same author

Risk factors for second acute myeloid leukemia/myelodysplastic syndrome among survivors of non-Hodgkin lymphoma.

Leukemia·2015
Same journal

Palliative Therapy for Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Ablative Therapies for Liver Tumors.

Hematology/oncology clinics of North America·2026
Same journal

Pathology of Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Minimally Invasive Surgery for Liver and Biliary Tract Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Surgical Considerations for Primary Liver Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Systemic Therapy for Biliary and Liver Neoplasms: Chemotherapy and Immunotherapy.

Hematology/oncology clinics of North America·2026
See all related articles

Patients cured of Hodgkin

Area of Science:

  • Oncology
  • Cancer Epidemiology

Background:

  • Hodgkin's disease treatment, including radiation and chemotherapy, offers high cure rates.
  • Survivors of Hodgkin's disease face an increased risk of developing secondary solid tumors later in life.

Purpose of the Study:

  • To highlight the significant risk of secondary solid tumors in Hodgkin's disease survivors.
  • To emphasize the need for understanding the epidemiology of these subsequent cancers.

Main Methods:

  • Review of patient outcomes following Hodgkin's disease treatment.
  • Analysis of the types and incidence of secondary solid tumors.

Main Results:

  • Hodgkin's disease survivors are at elevated risk for various solid tumors.
  • Common secondary malignancies include non-Hodgkin's lymphomas, lung cancers, sarcomas, and gastrointestinal cancers.

Related Experiment Videos

Conclusions:

  • Long-term survivors of Hodgkin's disease require monitoring for secondary solid tumors.
  • Further research into the epidemiology of these cancers is crucial for developing risk-reduction strategies.